Skip to main content
Top
Published in: Journal of Translational Medicine 1/2020

Open Access 01-12-2020 | Filgrastim | Research

Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors

Authors: Soo-Zin Kim-Wanner, Seo-Youn Lee, Erhard Seifried, Halvard Bonig

Published in: Journal of Translational Medicine | Issue 1/2020

Login to get access

Abstract

Background

Healthy volunteer registry donors have become the backbone of stem cell transplantation programs. While most registrants will never become actual donors, a small minority are called upon twice, most commonly for the same patient because of poor graft function. Anecdotal evidence provides no hard reasons to disallow second-time mobilized apheresis, but few centers have treated enough two-time donors for definitive conclusions. Moreover, for reasons unknown, the efficiency of G-CSF varies greatly between donations.

Methods

Comparison of outcomes of first vs. second donations can formally confirm G-CSF responsiveness as intrinsically, likely genetically, determined. In our database, we identified 60 donors (1.3%) who received two cycles of G-CSF 24 days to 4 years apart and systematically compared mobilization outcomes.

Results

First and second mobilization and collection proceeded without severe or unusual adverse effects. First-time mobilization efficiency was highly predictive of second-time mobilization. Neither mobilization efficiency nor time lag between donations affected the similarity of first- and second-time mobilization outcomes.

Conclusions

With the caveat that only donors with an unremarkable first donation were cleared for a second, our data indicate that a second donation is feasible, equally tolerable as a first donation, and efficient. Moreover, the data strongly support the notion of donor-intrinsic variables dictating mobilization response and argue against relevant damage to the stem cell compartment during mobilization with rhG-CSF.
Literature
1.
go back to reference Miller JP, Perry EH, Price TH, Bolan CD, Karanes C, et al. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2008;14(9 Suppl):29–36.CrossRef Miller JP, Perry EH, Price TH, Bolan CD, Karanes C, et al. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2008;14(9 Suppl):29–36.CrossRef
2.
go back to reference Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604–11.CrossRef Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604–11.CrossRef
3.
go back to reference Schmidt AH, Mengling T, Hernández-Frederick CJ, Rall G, Pingel J, et al. Retrospective analysis of 37,287 observation years after peripheral blood stem cell donation. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2017;23(6):1011–20.CrossRef Schmidt AH, Mengling T, Hernández-Frederick CJ, Rall G, Pingel J, et al. Retrospective analysis of 37,287 observation years after peripheral blood stem cell donation. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2017;23(6):1011–20.CrossRef
4.
go back to reference Platzbecker U, Bornhäuser M, Zimmer K, Lerche L, Rutt C, et al. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells. Transfusion. 2005;45(1):11–5.CrossRef Platzbecker U, Bornhäuser M, Zimmer K, Lerche L, Rutt C, et al. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells. Transfusion. 2005;45(1):11–5.CrossRef
5.
go back to reference Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, et al. Donor experiences of second marrow or peripheral blood stem cell collection mirror the first, but CD34+ yields are less. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2018;24(1):175–84.CrossRef Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, et al. Donor experiences of second marrow or peripheral blood stem cell collection mirror the first, but CD34+ yields are less. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2018;24(1):175–84.CrossRef
6.
go back to reference Tichelli A, Passweg J, Hoffmann T, Gregor M, Kühne T, et al. Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency. Br J Haematol. 1999;106(1):152–8.CrossRef Tichelli A, Passweg J, Hoffmann T, Gregor M, Kühne T, et al. Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency. Br J Haematol. 1999;106(1):152–8.CrossRef
7.
go back to reference La Rubia J, de, Arbona C, Del Cañizo C, Arrieta R, Arriba F de, , et al. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields. J Hematother Stem Cell Res. 2002;11(4):705–9.CrossRef La Rubia J, de, Arbona C, Del Cañizo C, Arrieta R, Arriba F de, , et al. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields. J Hematother Stem Cell Res. 2002;11(4):705–9.CrossRef
8.
go back to reference Stroncek DF, Clay ME, Herr G, Smith J, Ilstrup S, et al. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion. 1997;37(3):304–8.CrossRef Stroncek DF, Clay ME, Herr G, Smith J, Ilstrup S, et al. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion. 1997;37(3):304–8.CrossRef
9.
go back to reference Wang T-F, Wen S-H, Chen R-L, Lu C-J, Zheng Y-J, et al. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2008;14(11):1305–11.CrossRef Wang T-F, Wen S-H, Chen R-L, Lu C-J, Zheng Y-J, et al. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2008;14(11):1305–11.CrossRef
10.
go back to reference Lenk J, Bornhauser M, Kramer M, Hölig K, Poppe-Thiede K, et al. Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donors. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2013;19(10):1517–21.CrossRef Lenk J, Bornhauser M, Kramer M, Hölig K, Poppe-Thiede K, et al. Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donors. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2013;19(10):1517–21.CrossRef
11.
go back to reference Schulz M, Karpova D, Spohn G, Damert A, Seifried E, et al. Variant rs1801157 in the 3’UTR of SDF-1ß does not explain variability of healthy-donor G-CSF responsiveness. PLoS ONE. 2015;10(3):e0121859.CrossRef Schulz M, Karpova D, Spohn G, Damert A, Seifried E, et al. Variant rs1801157 in the 3’UTR of SDF-1ß does not explain variability of healthy-donor G-CSF responsiveness. PLoS ONE. 2015;10(3):e0121859.CrossRef
12.
go back to reference Garciaz S, Sfumato P, Granata A, Imbert A-M, Fournel C, et al. Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF. PLoS ONE. 2020;15(3):e0228878.CrossRef Garciaz S, Sfumato P, Granata A, Imbert A-M, Fournel C, et al. Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF. PLoS ONE. 2020;15(3):e0228878.CrossRef
13.
go back to reference Martín-Antonio B, Carmona M, Falantes J, Gil E, Baez A, et al. Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. Haematologica. 2011;96(1):102–9.CrossRef Martín-Antonio B, Carmona M, Falantes J, Gil E, Baez A, et al. Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. Haematologica. 2011;96(1):102–9.CrossRef
14.
go back to reference Bräuninger S, Thorausch K, Luxembourg B, Schulz M, Chow KU, et al. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation. Bone Marrow Transplant. 2014;49(11):1419–25.CrossRef Bräuninger S, Thorausch K, Luxembourg B, Schulz M, Chow KU, et al. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation. Bone Marrow Transplant. 2014;49(11):1419–25.CrossRef
15.
go back to reference Becker P, Schwebig A, Brauninger S, Bialleck H, Luxembourg B, et al. Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance. Transfusion. 2016;56(12):3055–64.CrossRef Becker P, Schwebig A, Brauninger S, Bialleck H, Luxembourg B, et al. Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance. Transfusion. 2016;56(12):3055–64.CrossRef
16.
go back to reference Dauber K, Becker D, Odendahl M, Seifried E, Bonig H, et al. Enumeration of viable CD34(+) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit. Cytotherapy. 2011;13(4):449–58.CrossRef Dauber K, Becker D, Odendahl M, Seifried E, Bonig H, et al. Enumeration of viable CD34(+) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit. Cytotherapy. 2011;13(4):449–58.CrossRef
17.
go back to reference Hölig K, Kramer M, Kroschinsky F, Bornhäuser M, Mengling T, et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009;114(18):3757–63.CrossRef Hölig K, Kramer M, Kroschinsky F, Bornhäuser M, Mengling T, et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009;114(18):3757–63.CrossRef
18.
go back to reference Anderlini P, Przepiorka D, Seong C, Smith TL, Huh YO, et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion. 1997;37(5):507–12.CrossRef Anderlini P, Przepiorka D, Seong C, Smith TL, Huh YO, et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion. 1997;37(5):507–12.CrossRef
19.
go back to reference Velier M, Granata A, Bramanti S, Calmels B, Furst S, et al. A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution. Transfusion. 2019;59(11):3442–7.CrossRef Velier M, Granata A, Bramanti S, Calmels B, Furst S, et al. A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution. Transfusion. 2019;59(11):3442–7.CrossRef
20.
go back to reference Schmidt H, Schetelig J, Buhrmann K, Kozlova A, Hütter G, et al. Time dependent decrease in efficacy of second G-CSF mobilization in healthy unrelated donors. Blood. 2015;126(23):1895.CrossRef Schmidt H, Schetelig J, Buhrmann K, Kozlova A, Hütter G, et al. Time dependent decrease in efficacy of second G-CSF mobilization in healthy unrelated donors. Blood. 2015;126(23):1895.CrossRef
21.
go back to reference Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE. Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation. Transfusion. 2016;56(9):2331–5.CrossRef Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE. Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation. Transfusion. 2016;56(9):2331–5.CrossRef
22.
go back to reference de La Rubia J, Arbona C, de Arriba F, Del Cañizo C, Brunet S, et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion. 2002;42(1):4–9.CrossRef de La Rubia J, Arbona C, de Arriba F, Del Cañizo C, Brunet S, et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion. 2002;42(1):4–9.CrossRef
23.
go back to reference Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang. 2005;89(4):229–35.CrossRef Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang. 2005;89(4):229–35.CrossRef
24.
go back to reference Teipel R, Schetelig J, Kramer M, Schmidt H, Schmidt AH, et al. Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors. Transfusion. 2015;55(12):2855–63.CrossRef Teipel R, Schetelig J, Kramer M, Schmidt H, Schmidt AH, et al. Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors. Transfusion. 2015;55(12):2855–63.CrossRef
25.
go back to reference Bogunia-Kubik K, Gieryng A, Dlubek D, Lange A. The CXCL12-3’A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. Bone Marrow Transpl. 2009;44(5):273–8.CrossRef Bogunia-Kubik K, Gieryng A, Dlubek D, Lange A. The CXCL12-3’A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. Bone Marrow Transpl. 2009;44(5):273–8.CrossRef
26.
go back to reference Szmigielska-Kaplon A, Szemraj J, Hamara K, Robak M, Wolska A, et al. Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2014;20(7):986–91.CrossRef Szmigielska-Kaplon A, Szemraj J, Hamara K, Robak M, Wolska A, et al. Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2014;20(7):986–91.CrossRef
27.
go back to reference Wong WH, Bhatt S, Trinkaus K, Pusic I, Elliott K, et al. Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation. Sci Translational Med. 2020;12(526). Wong WH, Bhatt S, Trinkaus K, Pusic I, Elliott K, et al. Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation. Sci Translational Med. 2020;12(526).
Metadata
Title
Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors
Authors
Soo-Zin Kim-Wanner
Seo-Youn Lee
Erhard Seifried
Halvard Bonig
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2020
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-020-02634-z

Other articles of this Issue 1/2020

Journal of Translational Medicine 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine